CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-01 | Burns James William Chief Legal Officer | Grant or award · Stock options (right to buy) | +44,000 | 44,000 | ||
| 2023-03-01 | Burns James William Chief Legal Officer | Option exercise · Restricted stock units | −3,833 | 7,667 | ||
| 2023-03-01 | Goff Brian Chief Executive Officer | Grant or award · Restricted stock units | +25,500 | 25,500 | ||
| 2023-03-01 | Goff Brian Chief Executive Officer | Grant or award · Stock options (right to buy) | +94,500 | 94,500 | ||
| 2023-03-01 | Gheuens Sarah Chief Medical Officer | Option exercise | +3,833 | 21,250 | ||
| 2023-03-01 | Gheuens Sarah Chief Medical Officer | Grant or award · Restricted stock units | +12,000 | 12,000 | ||
| 2023-03-01 | Gheuens Sarah Chief Medical Officer | Grant or award · Stock options (right to buy) | +44,000 | 44,000 | ||
| 2023-03-01 | Gheuens Sarah Chief Medical Officer | Option exercise · Restricted stock units | −3,833 | 7,667 | ||
| 2023-02-27 | Schenkein David P Director | Option exercise | +20,000 | $9.05 | $181K | 137,879 |
| 2023-02-27 | Schenkein David P Director | Sale | −20,000 | $25.37 | $507K | 117,879 |
| 2023-02-27 | Schenkein David P Director | Option exercise · Stock option (right to buy) | −20,000 | 56,363 | ||
| 2023-02-16 | Washburn Theodore James Jr. Principal Accounting Officer | Sale | −233 | $27.21 | $6K | 2,668 |
| 2023-02-16 | Burns James William Chief Legal Officer | Shares withheld for taxes | −609 | $28.91 | $18K | 23,538 |
| 2023-02-16 | FOUSE JACQUALYN A Director | Shares withheld for taxes | −3,648 | $28.91 | $105K | 82,582 |
| 2023-02-14 | Washburn Theodore James Jr. Principal Accounting Officer | Option exercise | +360 | 3,532 | ||
| 2023-02-14 | Washburn Theodore James Jr. Principal Accounting Officer | Shares withheld for taxes | −127 | $28.91 | $4K | 3,405 |
| 2023-02-14 | Washburn Theodore James Jr. Principal Accounting Officer | Sale | −504 | $28.59 | $14K | 2,901 |
| 2023-02-14 | Washburn Theodore James Jr. Principal Accounting Officer | Option exercise · Restricted stock units | −360 | 0 | ||
| 2023-02-14 | Burns James William Chief Legal Officer | Option exercise | +1,738 | 24,147 | ||
| 2023-02-14 | Burns James William Chief Legal Officer | Option exercise · Restricted stock units | −1,738 | 0 |
Page 31 of 48 · 941 trades